Combination therapies for treatment of cancer
US10111874B2 · kind B2 · utility
34Cited by
48References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2015 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Sep 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combination therapies for treatment of cancers associated with mutations in the KRAS gene are provided. Compositions comprising therapeutic agents for treatment of cancers associated with mutations in the KRAS gene are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.